These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34532374)

  • 1. Identification of solute-carrier family 27A molecules (SCL27As) as a potential biomarker of ovarian cancer based on bioinformatics and experiments.
    Chen H; Han T; Zhao Y; Feng L
    Ann Transl Med; 2021 Aug; 9(15):1237. PubMed ID: 34532374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.
    Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F
    Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping and tissue mRNA expression analysis of the pig solute carrier 27A (SLC27A) multigene family.
    Gallardo D; Amills M; Quintanilla R; Pena RN
    Gene; 2013 Feb; 515(1):220-3. PubMed ID: 23219995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insight on Solute Carrier Family 27 Member 6 (SLC27A6) in Tumoral and Non-Tumoral Breast Cells.
    Yen MC; Chou SK; Kan JY; Kuo PL; Hou MF; Hsu YL
    Int J Med Sci; 2019; 16(3):366-375. PubMed ID: 30911270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
    Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
    BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
    Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
    Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundance of solute carrier family 27 member 6 (
    Zhang H; Shen Z; Yang Z; Jiang H; Chu S; Mao Y; Li M; Chen Z; Aboragah A; Loor JJ; Yang Z
    Food Funct; 2021 Jun; 12(11):4909-4920. PubMed ID: 34100479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl-4-Hydroxylase α Subunit 2 as a Novel Potential Biomarker for Predicting the Prognosis of Epithelial Ovarian Carcinoma.
    Zhang H; Zhao W
    Cancer Manag Res; 2021; 13():4455-4462. PubMed ID: 34113171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Expression of Very-Long-Chain Acyl-CoA Synthetases
    Korbecki J; Kojder K; Jeżewski D; Simińska D; Tomasiak P; Tarnowski M; Chlubek D; Baranowska-Bosiacka I
    Brain Sci; 2023 May; 13(5):. PubMed ID: 37239243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment.
    Zhu Y; Zhang Z; Jiang Z; Liu Y; Zhou J
    Front Genet; 2020; 11():369. PubMed ID: 32425977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
    Zhao J; Gao H; He Y
    Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism.
    Zhong X; Yang Y; Li B; Liang P; Huang Y; Zheng Q; Wang Y; Xiao X; Mo Y; Zhang Z; Zhou X; Huang G; Zhao W
    Front Oncol; 2021; 11():780410. PubMed ID: 35047398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification.
    Zhang M; Wang J; Yue H; Zhang L
    Front Genet; 2022; 13():918319. PubMed ID: 36110202
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.
    Bai Y; Li LD; Li J; Lu X
    J Ovarian Res; 2016 Jun; 9(1):35. PubMed ID: 27315793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY; Wei P; Qu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
    Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
    Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.